HK Stock Market Move | POU SHENG INT'L (03813) rose over 7% again, with a nearly 30% year-on-year increase in net profit for the first half of the year, and a payout ratio reaching 60%.
Baosheng International (03813) has risen over 7% again, and as of the time of this report, it is up 7.25%, priced at HKD 0.37, with a transaction amount of HKD 1.2481 million.
POU SHENG INT'L (03813) has risen over 7% again, currently up 7.25% at HKD 0.37, with a transaction volume of HKD 1.2481 million.
In terms of news, POU SHENG INT'L recently announced its performance for the first half of the year, with operating revenue of 8.9646 billion yuan (RMB, the same below), a year-on-year decrease of 2.1%; profit attributable to owners of the company was 244 million yuan, an increase of 29.9% year-on-year; basic earnings per share were 4.70 cents, with a proposed interim dividend of HKD 0.016 per share and a special dividend of HKD 0.016 per share, totaling HKD 0.032, resulting in a payout ratio of 60%. As of June 30, 2026, the group had a total of 3,110 directly-operated stores in Greater China, a decrease of 298 stores compared to the same period last year.
Related Articles

HK Stock Market Move | LEE'S PHARM (00950) surged over 7% as ZK2401's new drug clinical trial application has been accepted by the NMPA in China.

Bank of America reiterates Rocket Lab (RKLB.US) "Buy" rating: Short-term launch disruptions are noise; the core valuation focuses on the 2026 Neutron maiden flight.

Zhongtai: The insurance sector's asset-liability management shows results; August is expected to continue the relative and absolute return contributions seen in July.
HK Stock Market Move | LEE'S PHARM (00950) surged over 7% as ZK2401's new drug clinical trial application has been accepted by the NMPA in China.

Bank of America reiterates Rocket Lab (RKLB.US) "Buy" rating: Short-term launch disruptions are noise; the core valuation focuses on the 2026 Neutron maiden flight.

Zhongtai: The insurance sector's asset-liability management shows results; August is expected to continue the relative and absolute return contributions seen in July.

RECOMMEND





